All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Fri 2018-12-07? to Fri 2025-12-19 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| MRNA × |
−20.95%
2025-12-19 |
1.41 TRR
2025-12-19 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07? to Fri 2025-12-19 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+41.01%
+5.01%/yr |
+3.38%/yr
(R2=0.005) |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07? to Fri 2025-12-19 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$14,100.96
2025-12-19 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Year | MRNA |
|---|---|
| 2025 (YTD) | −20.95% |
| 2024 | −59.36% |
| 2023 | −46.43% |
| 2022 | −33.57% |
| 2021 | +127.14% |
| 2020 | +426.96% |
| 2019 | +25.19% |
| 2018 | −17.69% |
| Fri 2018-12-07? to Fri 2025-12-19 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| MRNA × | −94.13% |
−96.11%
2025-11-20 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||